Assay devices having detection capabilities within the hook effect region

• US 7,439,079 B2
• Filed: 04/29/2005
• Issued: 10/21/2008
• Est. Priority Date: 04/29/2005
• Status: Active Grant

• Current Assignee: Kimberly-Clark Worldwide Incorporated (Kimberly-Clark Corporation)
• Original Assignee: Kimberly-Clark Worldwide Incorporated (Kimberly-Clark Corporation)
• Inventors: Christopher, Paul, Song, Xuedong
• Primary Examiner(s): Le; Long V.
• Assistant Examiner(s): DIRAMIO, JACQUELINE A
• Application Number:
  US11/119,262
• Publication Number:
  US 20060246601A1
• Time in Patent Office: 1,271 Days
• Field of Search: 422/55, 422/68.1, 435/4, 435/7.1, 435/287.1, 435/287.2, 435/287.7, 435/288.7, 436/501, 436/161, 436/164, 436/165, 436/166, 436/169, 436/172, 436/807, 436/518
• US Class Current: 436/518
• CPC Class Codes: G01N 33/54366 Apparatus specially adapted for solid-phase testing
• CPC Class Codes: G01N 33/54388 based on lateral flow
• CPC Class Codes: G01N 33/558 using diffusion or migration of antigen or antibody immunochromatographic test strips G01N33/54387
• CPC Class Codes: Y10S 436/807 Apparatus included in process claim, e.g. physical support structures

Abstract

A lateral flow assay device for detecting the presence or quantity of an analyte within a test sample is provided. The device utilizes multiple zones, one of which serves as an indicator of whether or not the analyte in the test sample is within the “hook effect” region. Based on this indication, a technique may be selected for correlating a measured signal intensity to an analyte concentration or range of concentrations. For example, when it is determined that the test sample falls outside the “hook effect” region, the analyte concentration may be determined using one portion of a dose response curve. On the other hand, when it is determined that the test sample falls within the “hook effect” concentration, the analyte concentration may be determined using another portion of the dose response curve. Alternatively, the sample may simply be diluted for re-performing the assay. The present inventor has discovered that such a detection technique may simply, quickly and accurately detect an analyte present at any concentration.

Claims

1. A method for quantitatively or semi-quantitatively detecting an analyte within a test sample, the method comprising:

i) contacting the test sample with a porous membrane of a lateral flow device, the porous membrane being in communication with conjugated detection probes, the conjugated detection probes being capable of generating a signal, the porous membrane defining;

a detection zone in which is immobilized a first receptive material, the first receptive material being configured to preferentially bind to the analyte, whether complexed or uncomplexed with the conjugated detection probes;

an indicator zone located downstream from the detection zone, wherein a second receptive material is immobilized within the indicator zone, the second receptive material being configured to preferentially bind to the uncomplexed conjugated detection probes;

ii) measuring the intensity of a detection signal produced at the detection zone and the intensity of an indicator signal produced at the indicator zone;

iii) comparing the measured indicator signal intensity to a reference standard, the reference standard representing an intensity or range of intensities of the indicator signal at or near a saturation concentration of the analyte;

iv) generating a dose response curve by plotting detection signal intensity for known analyte concentrations; and

v) converting the measured detection signal intensity to an analyte concentration or range of concentrations based on whether the measured indicator signal intensity is less than, greater than, or the same as the reference standard, wherein the concentration of the analyte in the test sample is determined using a first region of the dose response curve when the measured indicator signal intensity is greater than the reference standard, or the concentration of the analyte in the test sample is determined using a second region of the dose response curve when the measured indicator signal intensity is less than the reference standard, or wherein a third region of the dose response curve is used when the measured indicator signal intensity is the same as the reference standard, the third region providing a range within which the concentration of the analyte falls.

2. The method of claim 1, wherein a calibration signal intensity is also used to generate the dose response curve.

3. The method of claim 1, wherein the detection signal intensity of the dose response curve bears an approximate linear relationship to analyte concentration within the first region.

4. The method of claim 1, wherein the detection signal intensity of the dose response curve bears an approximate linear relationship to analyte concentration within the second region.

5. The method of claim 1, wherein the indicator signal intensity bears an approximate linear relationship to analyte concentration within the third region.

6. The method of claim 1, further comprising selectively controlling the concentration of a receptive material used to generate the dose response curve to help achieve a certain sensitivity range for the dose response curve.

7. The method of claim 1, further comprising selectively controlling the concentration of conjugated detection probes used to generate the dose response curve to help achieve a certain sensitivity range for the dose response curve.

8. The method of claim 1, wherein a second test sample is diluted for contact with the porous membrane when the measured indicator signal intensity is approximately the same as the reference standard.

9. The method of claim 1, wherein the first and second receptive materials are selected from the group consisting of antibodies, antigens, haptens, protein A, protein G, protein A/G, neutravidin, avidin, streptavidin, captavidin, as well as analogs thereof.

10. The method of claim 1, wherein the second receptive material has at least one epitope in common with the analyte.

11. The method of claim 10, wherein the second receptive material includes an antigen or an analog thereof.

12. The method of claim 11, wherein the first receptive material includes an antibody or an analog thereof.

13. The method of claim 1, wherein the detection probes comprise a substance selected from the group consisting of chromogens, catalysts, luminescent compounds, radioactive compounds, visual labels, liposomes, and combinations thereof.

14. The method of claim 1, wherein the detection probes comprise a luminescent compound.

15. The method of claim 1, wherein the detection probes comprise a visual label.

16. The method of claim 1, wherein the detection probes are conjugated with a specific binding member selected from the group consisting of antibodies, antigens, haptens, protein A, protein G, protein AIG, neutravidin, avidin, streptavidin, captavidin, and analogs thereof.

17. The method of claim 1, wherein the analyte is C-reactive protein.

18. The method of claim 1, wherein the porous membrane further defines a calibration zone that is capable of producing a calibration signal.

19. The method of claim 1, wherein the porous membrane further defines a control zone.

20. A method for quantitatively or semi-quantitatively detecting an antigen within a test sample, the method comprising:

i) contacting the test sample with a porous membrane of a lateral flow device, the porous membrane being in communication with conjugated detection probes, the conjugated detection probes being capable of generating a signal, wherein the antigen is capable of forming complexes with the conjugated detection probes, the porous membrane defining;

a detection zone in which is immobilized a first receptive material, the first receptive material comprising an antibody or an analog thereof that is configured to preferentially bind to the antigen, whether complexed or uncomplexed with the conjugated detection probes;

an indicator zone located downstream from the detection zone, wherein a second receptive material is immobilized within the indicator zone, the second receptive material comprising an antigen or an analog thereof that is configured to preferentially bind to uncomplexed conjugated detection probes;

ii) measuring the intensity of a detection signal produced at the detection zone and the intensity of an indicator signal produced at the indicator zone;

iii) comparing the measured indicator signal intensity to a reference standard, the reference standard representing an intensity or range of intensities of the indicator signal at or near a saturation concentration of the antigen;

iv) generating a dose response curve by plotting detection signal intensity for known antigen concentrations; and

v) converting the measured detection signal intensity to an antigen concentration or range of concentrations based on whether the measured indicator signal intensity is less than, greater than, or the same as the reference standard, wherein the concentration of the antigen in the test sample is determined using a first region of the dose response curve when the measured indicator signal intensity is greater than the reference standard, or the concentration of the antigen in the test sample is determined using a second region of the dose response curve when the measured indicator signal intensity is less than the reference standard, or wherein a third region of the dose response curve is used when the measured indicator signal intensity is the same as the reference standard, the third region providing a range within which the concentration of the antigen falls.

21. The method of claim 20, wherein a calibration signal intensity is also used to generate the dose response curve.

22. The method of claim 20, wherein the detection probes comprise a luminescent compound or a visual label.

23. The method of claim 20, wherein the antigen is C-reactive protein.